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Infections disturb metabolic homeostasis in many
contexts, but the underlying connections are not
completely understood. To address this, we use
paired genetic and computational screens in
Drosophila to identify transcriptional regulators of
immunity and pathology and their associated target
genes and physiologies. We show that Mef2 is
required in the fat body for anabolic function and
the immune response. Using genetic and bio-
chemical approaches, we find that MEF2 is phos-
phorylated at a conserved site in healthy flies and
promotes expression of lipogenic and glycogenic
enzymes. Upon infection, this phosphorylation is
lost, and the activity of MEF2 changes—MEF2 now
associates with the TATA binding protein to bind a
distinct TATA box sequence and promote antimicro-
bial peptide expression. The loss of phosphorylated
MEF2 contributes to loss of anabolic enzyme expres-
sion in Gram-negative bacterial infection. MEF2 is
thus a critical transcriptional switch in the adult fat
body between metabolism and immunity.
INTRODUCTION
Metabolic regulation is tightly and ubiquitously linked with im-
mune responses and inflammatory signaling (Hotamisligil,
2006). Prolonged or excessive immune activation can drive
metabolic disruption and cause wasting of fatty and lean tissues.
This effect is seen in many human infections; it is particularly
prominent in Gram-negative sepsis and in persistent bacterial in-fections such as tuberculosis (Schwenk and Macallan, 2000;
Tappy and Chiole´ro, 2007). Because of the many etiologies
behind infection-induced cachexia, numerous molecular mech-
anisms have been proposed to underlie this condition, with sig-
nals including lipid mediators and cytokines and transcription
factors including FOXO, NF-kB, AP-1, Stats, and nuclear recep-
tors acting singly or in combination (Tracey and Cerami, 1994;
Vallerie and Hotamisligil, 2010; Van den Berghe, 2002). It has
been a major challenge to the field to experimentally link any
one of these molecular mechanisms to observed metabolic
dysfunction following infection in vivo.
Chronic or acute infection disrupts systemic metabolism in
Drosophila as well as in vertebrates. We have previously shown
that infection with Mycobacterium marinum causes metabolic
disruptions in Drosophila resulting, in part, from a systemic loss
of AKT activity (Dionne et al., 2006). This promotes pathological
FOXOactivationandan inability toproducenewmetabolic stores.
Activation of the Toll pathway in the fly fat body, either genetically
or by infection, is sufficient to partially phenocopy this effect, both
at the level of AKT activity andmetabolic storage (DiAngelo et al.,
2009). Listeria infection causes similar metabolic pathology
(Chambers et al., 2012). The function of the link between immune
activation and loss of anabolic signaling activity is unclear, espe-
cially because FOXO is able to activate antimicrobial peptide
expression but is not required for resistance to infection (Becker
et al., 2010).Howother anabolic or catabolic pathwaysarealtered
by infection in flies is also unknown, though it is clear that there are
other common regulators of these processes, at least at the level
of the whole organism (Rynes et al., 2012).
We used a paired screening strategy to identify the pathways
and transcriptional networks that regulate host physiology in vivo
in response to infection. One screen used computational anal-
ysis of gene expression after different immune challenges to
identify coregulated genes and their predicted transcriptionalCell 155, 435–447, October 10, 2013 ª2013 The Authors 435
AB
Figure 1. Computational Predictions for
Transcriptional Regulators of Infection
(A) Diagram of our approach.
(B) Expression and predicted regulation of gene
clusters. Left, log2(infection/control) of the median
of each cluster in each infection condition (yellow
indicates increasedmRNA level after infection, blue
indicates decreased). Right, predicted transcrip-
tion-factor associations of each cluster, as well as
predictions derived from analysis of the entire sets
of transcripts up- and downregulated after
M. marinum infection. + indicates p % 0.02 (over-
represented sites),  indicates 0.98 % p (under-
represented sites). Genotypes: spz, spa¨tzle (Toll
pathway)mutant;Rel,Relish (imdpathway)mutant.
Infections:Mm,M.marinum; fungus/fun.,Beauvaria
bassiana; septic injury, mixedM. luteus and E. coli.
See also Figure S1 and Tables S1 and S2.regulators. The other screen involved testing mycobacterial
infection susceptibility of flies carrying targeted RNAi knock-
downs of transcription factors and signaling intermediates.
These screens converged on MEF2, a pleiotropic transcription
factor originally characterized as a key factor in muscle develop-
ment (Bour et al., 1995; Lilly et al., 1995; Molkentin et al., 1995).
Our data reveal that MEF2 regulates immune and metabolic
activities, as depletion of MEF2 in the fat body causes dramatic
failures of systemic anabolism and immune function. This results
from reduced expression of key metabolic enzymes and antimi-
crobial peptides, respectively. The choice between immune and
metabolic target genes is dictated by phosphorylation of MEF2
at a conserved site. In healthy animals, MEF2 is phosphorylated
at T20 and promotes expression of its metabolic targets,
whereas infection results in T20 dephosphorylation and associ-
ation with the TATA-binding protein (TBP) at a distinct TATA
sequence of immune targets.436 Cell 155, 435–447, October 10, 2013 ª2013 The AuthorsRESULTS
Computational and Functional
Screens Reveal Mef2 as a
Regulator of Infection
Susceptibility
To identify new factors in the response to
infection, we performed two screens. In
the first, we analyzed a large microarray
data set reflecting whole-fly gene expres-
sion at multiple times after several
different infections (for details, see Fig-
ure 1 and supporting material) (De Gre-
gorio et al., 2001, 2002; Dionne et al.,
2006). This data set included wild-type
animals as well as loss-of-function mu-
tants in the imd and Toll pathways, the
two primary microbe-detection systems
in the fly. These two pathways respond
to different microbes and share nomolec-
ular components but regulate overlap-
ping sets of target genes because eachculminates in activation of a distinct NF-kB family member
(Lemaitre and Hoffmann, 2007). We used fuzzy c-means clus-
tering to find clusters of genes coregulated across biological
conditions and then identified transcription factor binding sites
overrepresented in the vicinity of the genes within each cluster
(Figure 1 and Tables S1 and S2 available online). These binding
sites represent potential regulators of the associated genes.
This type of computational analysis affords direct identifica-
tion of transcriptional effectors, their targets, and regulated
physiologies simultaneously without prior knowledge. This is re-
flected in the fact that many of our coregulated groups of genes
correspond to clear biological functions. In keeping with our pre-
vious observation of metabolic dysregulation in Mycobacterium
marinum-infected flies, metabolic functions were overrepre-
sented in 6 of the 30 clusters (Figure S1), suggesting that the
shared transcriptional regulators of these clusters may have
important metabolic roles.
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Figure 2. Infection Susceptibility of Fat Body Mef2 Knockdowns
(A–D) Survival of Mef2 knockdown (w1118/Y ; c564/+ ; UAS-Mef2-IR/+) or
control (w1118/Y ; c564/+) flies after different infections. TwoMef2 knockdown
lines are shown for E. cloacae; all phenotypes were observed with both lines,
but only one line is typically shown for simplicity. p values for differences in
survival times between control and Mef2 knockdowns by log-rank test:
M. marinum 5,000 colony-forming units (CFU), p = 3.89*109;M. marinum 500
CFU, p = 9.35*1014; Listeria, p = 0; E. cloacae, 15,549, p = 0; E. cloacae,
15,550, p = 0; Candida, p = 5.07*108.
(E) E. cloacae CFU per fly, input, and 7 hr after infection in driver-only controls
and two Mef2 knockdowns. Seven individual animals are shown for each
condition. Line indicates the median. Points or lines in gray exceeded the
maximum range of the assay (109 CFU/fly).
(F) M. marinum numbers per fly assayed by qRT-PCR after an initial infection
with 5,000 CFU. Values are mean ± SEM.
See also Figure S2.To test in vivo function of predicted regulators, we performed
a secondary functional screen, testing time to death after
M. marinum infection in flies with ubiquitous or fat-body-specific
RNAi knockdown of 29 transcription factors or signals associ-
ated with specific factors predicted to directly regulate gene
clusters after infection. Five genes gave clear survival pheno-
types; of these, Mef2 was particularly intriguing, being associ-
ated both with immune-response genes (cluster P) and with
metabolic activities (cluster X). We further analyzed Mef2 as a
potential nodal point between immune activation and metabolic
disruption.
Mef2 Regulates Susceptibility to Infection
The fat body, a homolog of mammalian liver and adipose tissue,
is both the primary source of the inducible humoral immune
response and the site of metabolic stores in the fly. Because
strong loss-of-function mutants in Mef2 are embryonic lethal
(Bour et al., 1995; Lilly et al., 1995), we tested animals with
Mef2 RNAi knockdown driven by c564, a driver strongly ex-
pressed in the fat body (Hrdlicka et al., 2002). Flies carrying fat
body Mef2 RNAi exhibited a significant reduction in survival
time after a high-dose M. marinum infection compared with
driver-only controls (Figure 2A). This survival effect was strength-
ened at lower bacterial doses.
To determine whether MEF2 is generally required for survival
after infection, we assayed survival of fat body Mef2 knock-
downs after other infections. In addition to M. marinum, these
animals were compromised in response to a second intracellular
pathogen, Listeria monocytogenes (Figure 2B). Moreover, unlike
wild-type animals, they were killed by infection with either Enter-
obacter cloacae or Candida albicans (Figures 2C and 2D). De-
fense against these infections is mediated specifically by the
imd and Toll pathways, respectively (Gottar et al., 2006). Sensi-
tivity of flies lacking fat body Mef2 to E. cloacae, in particular,
was similar to that of imd pathway mutants (Figure S2A) (Gottar
et al., 2006; Hedengren et al., 1999). This could be explained if
these flies lacked the fat body, but we found no visible reduction
in fat body mass or decrease in c564-driven GFP expression
(Figure S2B). All phenotypes were tested with a second Mef2
knockdown line, which gave similar or identical results in all
cases (Figure 2C and data not shown). Both lines eliminated
detectable fat body MEF2 protein when driven with c564 (Fig-
ure S2C). Other fat body drivers recapitulated the susceptibility
to E. cloacae (Figure S2D), and the susceptibility resulting from
Mef2 knockdown was rescued by coexpression of wild-type
Mef2 (Figure S2E).
We then assayed bacterial numbers in animals infected with
E. cloacae orM.marinum. In each case, more bacteria were pre-
sent in Mef2 knockdown animals (Figures 2E and 2F). The dra-
matic increase in E. cloacae number suggests that the effect
on this infection may be fully accounted for by defects in bacte-
ricidal activity. By contrast, the modest difference observed in
M. marinum number suggests that, in a more complex, chronic
infection, MEF2 is also important in tolerance of pathology.
Mef2 Is Required for Normal Fat and Glycogen Storage
As mentioned earlier, our data set included many genes encod-
ing metabolic activities. Cluster X, a predicted MEF2 targetCell 155, 435–447, October 10, 2013 ª2013 The Authors 437
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Figure 3. Metabolic Effects of Mef2 Knock-
down
(A) Expression of genes encoding enzymes of
triglyceride and fatty acid synthesis, glucose up-
take, and glycogen synthesis in control (w1118/Y ;
c564/+), Mef2 knockdown (w1118/Y ; c564/+ ;
UAS-Mef2-IR/+), and rescued (w1118/Y ; c564/
UAS-Mef2.HA ; UAS-Mef2-IR/+) flies, assayed by
qRT-PCR. mRNA levels are normalized to the
control genotype (w1118/Y ; c564 / +) and
expressed as log2. Values are mean ± SD. Signif-
icance levels: *p < 0.01 and **p < 0.001 by heter-
oscedastic unpaired two-tailed t test.
(B) Total triglyceride, glycogen, and free glucose
measured by colorimetric enzymatic assay inMef2
knockdown flies compared with driver-only con-
trols.
(C) Neutral lipids stained by oil red O in driver-only
control andMef2 knockdown fat body. Red, oil red
O; blue, DAPI. Scale bars, 20 mm.
See also Figure S3 and Table S3.cluster, contained several key metabolic enzymes, including
acetyl-CoA carboxylase (ACC), diacylglycerol acyltransferase
(mdy), and fat body hexose kinase (Hex-C). In addition to being
repressed by M. marinum infection, cluster X was rapidly and
transiently downregulated 3–6 hr after septic injury (infection
with a mixture of nonpathogenic Gram-positive and Gram-nega-
tive bacteria), with most genes returning to baseline within 24 hr
(Figure 1B). In addition to genes in cluster X, genes encoding key
anabolic enzymes in clusters Y and AA, as well as unclustered
genes, were repressed after eitherM. marinum infection or sep-
tic injury. These observations led us to examine the effects of
MEF2 on the expression of cluster X genes—and other anabolic
enzymes showing similar expression—in the absence of
infection.
Mef2 knockdown reduced expression of numerous key en-
zymes in fatty acid and triglyceride synthesis, including ACC,
mdy, fatty acid synthase (FASN/CG3523), ATP citrate lyase
(ATPCL), glycerol-3-phosphate dehydrogenase (Gpdh), glycerol
kinase (Gk), and the mitochondrial citrate transporter (sea) (Fig-
ure 3A). A similar pattern was apparent for the enzymes of fat
body glucose uptake and glycogen synthesis, including Hex-C,
Tret1-1 (one of two GLUT family members highly expressed in
fat body [Chintapalli et al., 2007]), phosphoglucose mutase
(Pgm), UDP-glucose pyrophosphorylase (UGP), glycogen syn-
thase (GlyS/CG6904), and the glycogen branching enzyme
(AGBE) (Figure 3A, black bars). The expression of almost all
these genes was rescued by coexpression of wild-type Mef2
(Figure 3A, gray bars); for a few targets, this rescue was partial,
likely because the RNAi targeted the rescue transgene as well as
the endogenous locus. Genes that were incompletely rescued or438 Cell 155, 435–447, October 10, 2013 ª2013 The Authorsthat showed paradoxical repression in the
rescue-containing animals (FASN and
Hex-C) could also be repressed by induc-
ible expression of a Mef2-engrailed
repressor fusion (Blanchard et al., 2010),
confirming their dependence on Mef2
for expression (Figure S3A). However,the fat body was intact and continued to express glycogen
phosphorylase (GlyP), GFP driven by c564, and other fat-body-
enriched genes, indicating that Mef2 is not required for develop-
ment, survival, or overall identity of this tissue (Figures 3A
and S2).
In keeping with reduced expression of enzymes of glycogen-
esis (Hex-C, Pgm, UGP, GlyS, and AGBE) and lipogenesis
(sea, ATPCL, ACC, FASN, Gpdh, Gk, and mdy), unchallenged
Mef2 knockdown flies were almost entirely devoid of triglyceride
and glycogen (Figures 3B, 3C, S3B, and S3C). These animals
contained normal levels of free glucose and trehalose, suggest-
ing that, even without glycogen or triglyceride stores, they can
regulate circulating sugar (Figure 3B). These metabolic pheno-
types could be seen, though more weakly, with a second fat
body driver (Figures S3D and S3E; data not shown). Other fat
body drivers may give weaker phenotypes because they knock
down Mef2 less efficiently or because c564 also knocks down
Mef2 in other tissues (for example, the gut, which is lipogenic
and parts of which also exhibit c564-driven expression). As
would be expected,Mef2 knockdown animals died more rapidly
than wild-type flies when starved (Figure S3F). However, they
were not generally stress sensitive, exhibiting normal survival un-
der either hyperoxia or heat stress (Figures S3G–S3J).
These data suggest that the statistical association of pre-
dicted Mef2 sites with genes encoding key metabolic activities
reflects a requirement for Mef2 in normal expression of these
genes and thus in normal metabolic function. Although MEF2
may regulate its metabolic targets indirectly, we favor direct
regulation, as 12/13 of the identified metabolic target genes
have high-quality MEF2 binding sites within their 50 or 30 flanking
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Figure 4. Effects of Mef2 Knockdown on
Infection-Induced Gene Expression
Expression of antimicrobial peptides in control,
Mef2 knockdown, and rescued flies 3 or 6 hr after
injection of mixedM. luteus and E. coli assayed by
qRT-PCR and normalized to uninjected controls
(Drosophila genotypes as in Figure 3A). Values are
mean ± SD. Significance levels: *p < 0.01 and **p <
0.001 by heteroscedastic unpaired two-tailed
t test.
See also Figure S4.regions or in introns (Table S3). The severe metabolic defect in
Mef2 knockdown animals likely contributes to their short lifespan
after mycobacterial infection by decreasing their ability to with-
stand infection-induced wasting.
Mef2 Knockdown Impairs Humoral Immune Responses
AlthoughMef2 has not previously been described as an immune
regulator in Drosophila, our computational analysis also associ-
ated Mef2 sites with cluster P, which contains many genes
known to be targeted by NF-kB-like factors upon activation of
the imd or Toll pathways, including the antimicrobial peptides
Defensin, Metchnikowin, Drosocin, and Attacin A. These genes
are typically strongly induced within 3 hr of septic injury.
To test whether MEF2 regulates these genes, we examined
antimicrobial peptide response to septic injury in fat body Mef2
knockdown flies. We again infected flies with a mixture of the
imd agonist Escherichia coli and the Toll agonist Micrococcus
luteus. These are strong agonists of the respective pathways
but do not rapidly kill flies in which detection pathways are
mutated, permitting us to assay gene expression at late times
after infection. Fat bodyMef2 knockdown flies exhibited dramat-
ically reduced induction of AttA, CecA1, Def, Dpt, Dro, Drs, IM4,
and Mtk in response to this mixed infection (Figure 4, compare
black bars to white bars). Again, this could be rescued by coex-Cell 155, 435–447,pression of wild-typeMef2 (Figure 4, gray
bars), and again, the few genes that were
not completely rescued also exhibited
reduced induction in flies carrying an
inducible Mef2-EnR transgene (Fig-
ure S4A). This block was heterogeneous;
at least one antimicrobial peptide, Lister-
icin, was entirely unaffected (Figure 4).
We observed similar results in animals
that received single infections with either
bacterium (Figure S4B). That both Toll
and imd target genes were affected in
response to an infection activating both
pathways indicates that the role of
MEF2 is not specific to either pathway.
MEF2 and TBP Physically Interact
upon Infection to Bind AMP TATA
Boxes
To clarify the requirement for Mef2 in
expression of its immune targets, weexamined the requirement for individual MEF2 sites near antimi-
crobial peptides. We cloned putative regulatory regions (1.5 kb
50 to the ATG) from Drosocin and Metchnikowin upstream of
enhanced GFP (eGFP). This region included NF-kB, DEAF-1,
and GATA sites previously shown to regulate Mtk expression
(Reed et al., 2008; Senger et al., 2004) aswell asmultiple putative
MEF2 sites. In each case, a predicted MEF2 site overlapped the
TATA box (Dro site 3 andMtk site 2) (Figures 5A and S5). Individ-
ual putative MEF2 binding sites were mutated in these con-
structs, keeping the core TATA sequences intact; each Mef2
mutant TATA sequence replicated a naturally occurring, func-
tional TATA box not predicted to bindMEF2.We initially analyzed
reporter activity of wild-type and mutant constructs in S2* cells
treated with lipopolysaccharide (LPS) (commercial LPS contains
sufficient peptidoglycan to potently activate the imd pathway
[Kaneko et al., 2004]) (Figure S5). Both Dro-GFP and Mtk-GFP
were strongly induced by LPS, as expected. Distal MEF2 sites
were important for Dro reporter activity, but both Mtk and Dro
reporters required theMEF2-TATA box for normal induction (Fig-
ure S5). To test in vivo responses to infection, we made trans-
genic flies carrying the same eight GFP reporters, each inserted
into the AttP2 site. Uninfected, these animals exhibited weak or
no GFP fluorescence, but E. coli injection induced strong fat
body GFP activity in flies carrying the wild-type reportersOctober 10, 2013 ª2013 The Authors 439
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Figure 5. An Infection-Inducible MEF2-TBP
Complex Binds AMP TATA Boxes
(A) Requirement for MEF2 and TBP sites in AMP
regulation measured by eGFP fluorescence in
transgenic flies carrying indicated reporters 8 hr
after E. coli injection (general genotype: w1118; ;
AMP-eGFP[AttP2]/+). Twomale flies are shown for
each condition. In site maps, matches to theMEF2
consensus are capitalized, and matches to the
TATA consensus are underlined.
(B) MEF2 and TBP coimmunoprecipitate from
whole flies 3 hr after E cloacae infection; this
association is eliminated in Tak1 mutants, but not
in Dif; Rel double mutants.
(C) MEF2 and TBP bind theMtk TATA box. The top
indicates EMSA with 40 bp oligonucleotides cor-
responding sequences surrounding the wild-type
or non-MEF2-binding mutant (DM) TATA box.
Nuclear extracts are all from cells expressing
MEF2-HA. All lanes are from the same gel and
used the same extracts. The bottom indicates a
similar experiment, showing that anti-HA and anti-
TBP antibodies can inhibit formation of the same
complex.
(D) TATA box sequences from (top) unbiased 890-
TATA sample; (bottom) 27 AMPs and AMP-like
factors.
(E) Correlation of flanking residues in the 890-TATA
sample. Asterisks indicate significant enrichment
relative to unconstrained sample (*p < 0.01; **p <
0.001; assayed by binomial test).
See also Figure S5 and Tables S4 and S5.(Figure 5A). The requirement for MEF2 sites in vivo was similar to
that in vitro; in particular, the MEF2-TATA site was required in
each case (Figure 5A).
We then tested whether MEF2 and TBP interacted directly by
immunoprecipitating endogenous MEF2 from whole-fly lysates.
In adult flies infected with the imd agonist E. cloacae or a mixture
of M. luteus and E. coli, TBP coimmunoprecipitated with MEF2
(Figure 5B and data not shown). When stimulated by
E. cloacae, this association required the imd-activated JNKKK
Tak1 but was unimpaired in Dif; Rel double mutants, suggesting440 Cell 155, 435–447, October 10, 2013 ª2013 The Authorsa requirement for JNK signaling, but not
NF-kB, in MEF2-TBP complex formation
after Gram-negative infection (Figure 5B).
We next asked whether the MEF2-TBP
complex could bind the putative MEF2-
TATA site. The Dro MEF2-TATA site
(TCTATATAAAGC) was a near-perfect
match to the ideal MEF2A site as defined
by SELEX (KCTAWWWWTAGM) (Pollock
and Treisman, 1991), so we focused on
the more divergent Mtk MEF2-TATA site
(GCTATAAAAGC). This site eliminates
one of the central A/T nucleotides in the
MEF2 consensus, changing the spacing
between the two putative half-sites.
When assayed by EMSA, the Mtk core
promoter was bound by nuclear extractsfrom S2R+ cells transfected with Mef2-HA, causing two distinct
complexes to form: complex 1, at lower apparent molecular
weight, was strong and consistently present, whereas the
amount of complex 2 varied from experiment to experiment,
though it was always less abundant than complex 1 (Figure 5C).
Mutation of the putatively MEF2-binding C and G nucleotides
flanking the TATA box eliminated both complexes. Complex 1
was also eliminated by preincubation of extracts with antibodies
to either HA or TBP, indicating that this complex containedMEF2
and TBP together bound to the Mtk TATA sequence.
To test the generality of these observations, we examined the
promoters of 30 antimicrobial peptides (AMPs) and other im-
mune-inducible small peptides (Table S4). Of these 30 genes,
27 had a TATA box, defined as TATAWA with the initial T
between57 and11 nucleotides relative to the annotated tran-
scription start site (TSS). The consensus sequence defined by
these 27 TATA boxes, CTATAWAAGM, is identical to the Mtk
MEF2-TATA box (Figure 5D and Table S4). 17/27 AMP TATAs
match this consensus; 3/27 instead match the Dro site, CTATA
TAAAGC. The remaining seven TATA boxes include at least
one nonconsensus nucleotide in the C...AGM flanks. The Mtk
and Dro-like sites were found on peptides from many structural
families, implying that this is not an ancestral sequence main-
tained by lack of counterselection. Conversely, the 13 metabolic
genes shown in Figure 3A had a total of 27 TSSs; of these, 5 had
TATA boxes, none of which matched the extended consensus
associated with antimicrobial peptides.
We then examined roughly 15,000 unique promoters drawn
from four databases of precisely mappedDrosophila TSSs (Hos-
kins et al., 2011; Ni et al., 2010; Rach et al., 2009; Schmid et al.,
2006). This identified 890 TATA-containing promoters, with
TATA boxes defined by the same criteria used for antimicrobial
peptides (Table S5). The median TATA box position was 31 nu-
cleotides upstream of the TSS (25–75 percentile range, 30–33
nucleotides) (Figure S5B). This set of TATA boxes contained 13
sequences that had been in our ‘‘training set’’ of AMPs and
AMP-like peptides; these were not removed—and the other
AMP TATAs were not added to this set—to avoid functionally
biasing the represented genes. AMP promoters were more likely
to contain a TATA box than those in the unbiased set (27/30
TATA-containing AMP promoters versus 890/15,000 TATA-con-
taining promoters in the unbiased analysis). Unlike AMP TATA
boxes, the 890 unbiased TATA boxes showed little nucleotide
preference outside the core TATAWA, except a preference for
A or T in the immediate 30 position (Figure 5D).
If the nucleotides flanking the core TATAWAmotif permit regu-
lation of TATA usage via MEF2-TBP interaction, then the identi-
ties of these nucleotides should be correlated—the presence of
a 50 C should predict the presence of a 30 AGM and vice versa.
We examined the relationships among flanking nucleotide posi-
tions within the 890 unbiased TATA boxes. In each case, TATA
boxes that fit theMtk-like TATA consensus at one flanking nucle-
otide weremore likely to match this consensus at other positions
as well. For example, in the initial set, 27.1% of TATA boxes con-
tained a C directly 50 of the TATAWA core. Fixing the nucleotide
30 of the TATAWA as A increased this representation to 34.2%,
fixing the two 30 nucleotides as AG gave a further increase to
38.3%, and fixing the three 30 nucleotides as AGM increased
the representation to 41.4% (Figure 5E).
We extracted from our set of TATA-containing promoters
those matching the Mtk-like or Dro-like consensus. This gave
88 genes (Table S5). In addition to antimicrobial peptides, this
list contained other infection-regulated genes and genes
involved in responses to a variety of stresses. It also contained
larval cuticular proteins, genes involved in sensory development
or function, and 13 different uncharacterized small proteins with
predicted secretory signals. The Gene Ontology terms ‘‘humoral
immune response,’’ ‘‘immune response,’’ ‘‘defense response,’’and ‘‘antimicrobial humoral response’’ were overrepresented
among genes with MEF2-TATA sequences as compared with
the full set of 890 TATA-containing genes (Bonferroni-corrected
p < 0.01).
These data together indicate that infection drives formation of
a MEF2-TBP complex that can bind the TATA box of many anti-
microbial peptides and is required for normal transcriptional in-
duction of these genes. That the flanking nucleotide positions
do not vary independently and the MEF2-TBP TATA box is over-
represented on immune genes both suggest that the MEF2-TBP
TATA box represents a previously uncharacterized discrete gene
regulatory element.
MEF2 Is Phosphorylated In Vivo at T20 to Regulate
Association with TBP
The mechanisms by which the infection-inducible MEF2-TBP
complex might be regulated and its potential function in MEF2
regulation of metabolic targets were unclear. We returned to
our microarray data to directly compare expression of the meta-
bolic and immune genes we had identified as Mef2 regulated.
After bacterial infection, these genes were strikingly counterre-
gulated; when the antimicrobial genes were induced, expression
of themetabolic geneswas lost. This was especially pronounced
3 and 6 hr after septic injury and in late-stage mycobacterial
infection (Figure 6A). This observation suggested that MEF2
modification might underlie a choice between immune and
metabolic targets.
MEF2 activity can be regulated by several mechanisms,
including phosphorylation by p38 MAP kinase, a calcineurin-
regulated acetylation/sumoylation switch, and an indirect mech-
anism involving phosphorylation-regulated recruitment of class II
histone deacetylases (Berdeaux et al., 2007; Han et al., 1997;
Shalizi et al., 2006; Zhang et al., 2002). In agreement with previ-
ous work (Chen et al., 2010; Dijkers and O’Farrell, 2007), neither
p38 nor calcineurin significantly altered immune competence in
adult flies (data not shown).
MEF2 phosphorylation at T20, within the DNA-binding
domain, can promote binding of MEF2 to a consensus MEF2-
dimer binding sequence that does not contain a central TATAWA
(Wang et al., 2005). The T20 region is conserved in Drosophila,
C. elegans, and all mouse and human MEF2 homologs, and it
matches a crude consensus site for AKT and p70 S6 kinase (Fig-
ure 6B). Using a phosphomotif antibody (Moritz et al., 2010), we
found that MEF2 T20 phosphorylation was detectable in extracts
from whole-adult Drosophila and was reduced in flies that had
received weak or strong immune challenges (PBS injection or
mixed infection with M. luteus and E. coli, respectively)
(Figure 6C).
To test the relevance of this phosphorylation in transcriptional
complex formation, we generated flies that inducibly expressed
HA-tagged wild-type MEF2, nonphosphorylatable MEF2 (T20A),
or phosphomimetic MEF2 (T20E) specifically in the fat body. One
week after eclosion, these flies were shifted from 18 to 29 to
drive Mef2*.HA expression. Because all transgenes were in-
serted into the same site, Mef2* constructs were expressed at
similar levels (Figure S6A).
We tested whether T20 directly regulated the association of
MEF2 with TBP by immunoprecipitating fat-body-expressedCell 155, 435–447, October 10, 2013 ª2013 The Authors 441
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Figure 6. T20 Phosphorylation Regulates MEF2-TBP Association
(A) Counterregulation ofMef2 targets after infection. Data are frommicroarrays discussed in text. Expression levels are normalized to uninfected controls. Values
are mean ± SD.
(B) The Mef2 T20 region is conserved in flies, humans, and C. elegans and matches an AKT/p70 S6 kinase consensus site.
(C) EndogenousMEF2 immunoprecipitated fromwhole flies is phosphorylated at T20; this phosphorylation is reduced by PBS injection or by infection with mixed
M. luteus and E. coli. Top indicates immunoprecipitated MEF2 probed with anti-MEF2 antibody; below indicates the same blot probed with anti-phospho-
RXRXXS/T* antibody; bottom indicates quantification of phospho-T20-MEF2 from the blot shown, normalized to total MEF2 and to the level in unmolested flies.
(D) Immunoprecipitation (IP) of inducible fat-body-expressedwild-type, T20A, or T20EMEF2.HA from flies either uninfected or infected 3 hr previously with mixed
E. coli andM. luteus, probedwith anti-HA (top) or for coimmunoprecipitated endogenous TBP (bottom). Genotype:w1118/Y ; c564/+ ; UAS-Mef2*.HA/tub-Gal80ts.
(E) T20 can be phosphorylated by p70 S6K in vitro. Purified GST or GST-MEF2tide fusions (wild-type or T20A) were incubated with 32P-g-ATP with or without
recombinant kinases and resolved by SDS-PAGE. Top indicates 32P autoradiogram; bottom indicates Coomassie blue stain.
(F) p70S6KThr398phosphorylation is reducedby infection. Top indicates representativewesternonwhole-fly lysatesprobedwith theantibodies indicated; bottom
indicates quantification of phospho-S6K normalized to tubulin from three independent experiments. Values aremean ±SD. Infections: Ec = E. coli (Gram-negative
imd agonist);Ml =M. luteus (Gram-positive Toll agonist). Uninjected animals were anaesthetized alongside injected animals but were otherwise unmolested.
See also Figure S6.
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MEF2*.HA either before or 3 hr aftermixed infection. Aswas seen
for the endogenous protein, wild-type MEF2.HA associated with
endogenous TBP only after infection (Figure 6D). Nonphosphor-
ylatable MEF2 associated with TBP even in the absence of infec-
tion; this association was strengthened by infection, suggesting
that otherMEF2 or TBPmodifications also contribute to complex
formation. In contrast, phosphomimetic MEF2 was not observed
to associate with TBP either before or after infection.
We wished to identify a kinase or kinases responsible for
MEF2 T20 phosphorylation in the Drosophila fat body. Others
have observed MEF2C T20 phosphorylation by protein kinase
A (PKA) and AKT (Wang et al., 2005). As PKA activation inhibits
glycogenesis and promotes lipolysis and as AKT activity is
reduced by infection in Drosophila, we initially focused on
AKT as a likely T20 kinase. However, we were unable to
observe phosphorylation of this site by AKT in vitro (Figure 6E).
Like AKT, p70 S6 kinase (S6K) is broadly anabolic in its effects
and is activated by nutrient signals. S6K shares with AKT its
preference for substrates with arginine at 5 and 3 (Alessi
et al., 1996). T20 was efficiently phosphorylated by recombinant
S6K in vitro (Figure 6E), and systemic S6K activation (measured
by phosphorylation at T398, corresponding to T389 in human
S6K) was reduced in flies that had received infections with
Toll or imd agonists (Figure 6F). A similar effect was seen during
the last 3 days of life in flies infected with M. marinum (Fig-
ure S6B). S6K is thus a plausible in vivo MEF2 T20 kinase
and may be responsible for promoting expression of the en-
zymes of lipogenesis and glycogenesis in healthy, well-fed
animals.
T20 Regulates the Ability of MEF2 to Promote Distinct
Target Genes and Physiologies
Together, these data suggested that loss of MEF2 T20 phos-
phorylation might cause the loss of anabolic transcripts seen
after infection and that loss of T20 phosphorylation might be
permissive for antimicrobial peptide expression. To test this
model, we measured expression of immune and metabolic
MEF2 targets in uninfected and infected animals inducibly
expressing wild-type Mef2, Mef2T20E, Mef2T20A, or driver-only
controls. In most cases, overexpression of wild-type MEF2
had small effects on either the loss of metabolic transcripts or
the induction of antimicrobial peptides after infection when
compared to the effects of infection in driver-only controls (Fig-
ures 7A and S7). Expression of nonphosphorylatable MEF2
enhanced expression of antimicrobial peptides (by as much
as 6-fold, in the case of Defensin) after either M. luteus or
E. cloacae infection but had little effect on most metabolic
genes. Conversely, expression of phosphomimetic MEF2 had
little general effect on antimicrobial peptides and did not coun-
teract the loss of most anabolic transcripts afterM. luteus infec-
tion but rescued levels of anabolic transcripts after E. cloacae
infection.
Together, these data indicate that T20 phosphorylation can
regulate the association of MEF2 with TBP, switching MEF2
betweenmetabolic and immune functions. The loss of metabolic
gene expression driven by imd pathway activation (typically
caused by Gram-negative bacterial infection) stems, at least in
part, from the loss of T20-phosphorylated MEF2.DISCUSSION
Here, we identifyMef2 as a factor critical for energy storage and
the inducible immune response in the Drosophila fat body. Many
infection-induced antimicrobial peptides depend on Mef2 for
normal expression. In consequence, flies lacking Mef2 activity
in the fat body are severely immunocompromised against a
variety of infections. Mef2 sites are also associated with genes
encoding key enzymes of anabolism, and Mef2 is required for
normal expression of these genes; consequently, flies lacking
Mef2 function in the fat body exhibit striking reductions in the
total levels of triglyceride and glycogen. These two groups of
target genes are counterregulated during infection; the anabolic
targets of Mef2 are reduced in expression when antimicrobial
peptides are induced. We show that fat body MEF2 can exist
in two states with distinct physiological activities. In uninfected
animals, MEF2 is phosphorylated at T20 and can promote the
expression of its metabolic targets. In infected animals, T20 is
dephosphorylated, and MEF2 associates with the TATA-binding
protein to bind a compound MEF2-TATA sequence found in the
core promoters of antimicrobial peptides. The loss of T20-phos-
phorylated MEF2 promotes the loss of anabolic transcripts in
flies with Gram-negative bacterial infection. These data, taken
together, suggest that the central role of MEF2 in promoting
fat body anabolism and immune activity reflects a switch be-
tween distinct transcriptional states regulated, at least in part,
by differential affinity for TBP determined by T20 phosphoryla-
tion (Figure 7B).
The signaling mechanisms regulating T20 phosphorylation
and MEF2-TBP association are clearly of critical importance.
The ability of p70 S6K to phosphorylate this residue is congruent
with the ability of S6K to enhance anabolism and repress catab-
olism in response to nutrient signals (Laplante and Sabatini,
2012). However, others have shown T20 phosphorylation by
PKA, suggesting that T20 phosphorylation may be regulated
by more than one pathway in vivo (Wang et al., 2005). The role
of TAK1may be similarly complex. TAK1 is required for formation
of the MEF2-TBP complex upon Gram-negative infection, but
this effect may be indirect. For example, reduced S6K phosphor-
ylation after infection may result from insulin resistance driven by
TAK1 via JNK (Chen et al., 2002; Hirosumi et al., 2002). TAK1-
dependent JNK activation is required for normal AMP induction
in vivo (Delaney et al., 2006), but it remains possible that some
novel pathway is the critical connection between TAK1 and
MEF2-TBP complex formation.
In mammals, in addition to hematopoietic roles, Mef2c regu-
lates B cell proliferation upon antigen stimulation (Khiem et al.,
2008; Wilker et al., 2008), and Mef2d regulates IL2 and IL10 in
T cells (Liopeta et al., 2009; Pan et al., 2004). The possibility
that Mef2 family proteins might be important direct activators
of innate responses has not previously been examined. We
show thatMef2 is a core transcriptional component of the innate
immune response of the adult fly. Equally, vertebrate Mef2 fam-
ily proteins are critical regulators of muscle metabolism, acti-
vated by physical activity to promote expression of PGC-1a
and the glucose transporter Glut4 (Handschin et al., 2003;
Thai et al., 1998; Wu et al., 2001). Glut4 regulation by MEF2 is
known in adipose tissue as well as in muscle (Thai et al.,Cell 155, 435–447, October 10, 2013 ª2013 The Authors 443
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Change in target gene expression after infection in flies due to expression
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Figure 7. T20 Phosphorylation Regulates Mef2 Target Choice in Infected Flies
(A) Effects of inducible fat body expression of wild-type, T20A, or T20EMef2 assayed by qRT-PCR.Genotypes are as in Figure 6D.Mef2 expressionwas activated
beginning 16 hr before infection. Left indicates the effect of infection in driver-only controls; right indicates changes due tomisexpression ofMef2mutants. Overall
significance of changes is assayed by Wilcoxon signed-rank test. All measurements are the mean of three biological replicates.
(B) Model. The position of Tak1 is unresolved: though shown upstream of S6K inactivation, it could also promote MEF2-TBP interaction in parallel with S6K
inactivation.
See also Figure S7.1998); it is an intriguing possibility that MEF2 is as important a
regulator of adipose metabolism in vertebrates as we show it
to be in flies.444 Cell 155, 435–447, October 10, 2013 ª2013 The AuthorsInfection-induced metabolic disruption leading to cachexia is
present in vertebrates as well as in insects, most notoriously in
Gram-negative sepsis and persistent bacterial infections such
as tuberculosis (Schwenk and Macallan, 2000; Tappy and Chio-
le´ro, 2007). Our data suggest that wasting seen after infection
may be due, in part, to the requirement for MEF2 to serve
different transcriptional functions in different conditions; the
MEF2 immune-metabolic transcriptional switch may be a mech-
anistic constraint that forces the fly into metabolic pathophysi-
ology in contexts of persistent immune activation. Alternatively,
the loss of MEF2-driven anabolic transcripts due to infection
may be productive, either by altering systemic energy usage
or by increasing the production or release of one or more antimi-
crobial metabolites. Recent work has highlighted a distinction
between ‘‘resistance’’ type immune mechanisms, in which the
host attempts to eradicate an invading organism, and ‘‘toler-
ance’’ type mechanisms, in which the host response is oriented
toward reducing the damage done by infection (Schneider and
Ayres, 2008). The distinct metabolic and immune requirements
for MEF2, combined with the obligation on the part of the host
to raise some measure of resistance to systemic infection,
may limit the achievable level of tolerance in persistent
infections.
EXPERIMENTAL PROCEDURES
Fly Culture, Stocks, and Infections
Flies were maintained at 25, 60% relative humidity, and on food containing
10% w/v Brewer’s yeast, 8% fructose, 2% polenta, and 0.8% agar. Adult
males were collected soon after eclosion and transferred to fresh food to
age prior to treatment. All phenotypes shown were observed with VDRC
Mef2-IR lines 15549 and 15550, which gave essentially identical results.
5- to 10-day-old adult male flies were injected with 50 nl of bacterial suspen-
sion or vehicle as described (Dionne et al., 2003). For survival, dead flies were
counted at 24 hr intervals or more frequently. Survival analyses were repeated
at least three times, always showing qualitatively similar results. Minimum
cohort size was 20 flies.
Antimicrobial peptide reporter expression was assayed in live flies using a
Leica M205 FA. Photographs were taken and processed using identical
settings.
Microarrays
Experimental aspects of array analysis have been described (De Gregorio
et al., 2001, 2002; Dionne et al., 2006). Data were reanalyzed using the
BioConductor suite in R.
Clustering of Probes, Binding-Site Predictions, and Functional
Predictions
We analyzed only probes significantly regulated (fold change > 1.5, p < 0.01) in
end-stage M. marinum samples (Dionne et al., 2006). Probes were clustered
by multiple rounds of fuzzy c-means clustering using MFuzz (Futschik and
Carlisle, 2005).
For each cluster, extended gene regions (gene sequence including introns
and UTRs, plus 2,000 bases flanking sequence) were analyzed with CLOVER
(Frith et al., 2004), using Drosophila chr 3R as background sequence.
Binding sites were tested against 20 false clusters of genes (genes selected
randomly from those represented on the Affymetrix Drosophila Genome 1
array and treated the same as true clusters). Sites predicted to regulate
more than two false clusters were eliminated from consideration.
Functional predictions were from Generic GO Term Finder (http://go.
princeton.edu/cgi-bin/GOTermFinder).
Biochemistry
EMSA, immunoprecipitation, kinase assays, and western blots were per-
formed according to standard protocols as described in the Extended Exper-
imental Procedures.Quantitative Real-Time RT-PCR
Performed as previously described (Clark et al., 2011; Dionne et al., 2006). All
data shown were the result of three to six biological replicates. Oligonucleo-
tides are listed in Table S6.
ACCESSION NUMBERS
The ArrayExpress accession number for the M. marinum microarray data
reported in this paper is E-MEXP-2510.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and six tables and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2013.09.007.
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